Skip to main content
Erschienen in: Diabetologia 10/2014

01.10.2014 | Article

CD40 promotes the development of early diabetic retinopathy in mice

verfasst von: Jose-Andres C. Portillo, Jennifer A. Greene, Genevieve Okenka, Yanling Miao, Nader Sheibani, Timothy S. Kern, Carlos S. Subauste

Erschienen in: Diabetologia | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Microangiopathy is a leading complication of diabetes that commonly affects the retina. Degenerate capillaries are a central feature of diabetic retinopathy. An inflammatory process has been linked to the development of diabetic retinopathy but its regulation is incompletely understood. Cluster of differentiation (CD) 40 is a member of the TNF receptor superfamily that promotes the development of certain inflammatory disorders. The role of CD40 in diabetic microangiopathy is unknown.

Methods

B6 and Cd40 −/− mice were administered streptozotocin to induce diabetes. Leucostasis was assessed using fluorescein isothiocyanate-conjugated concanavalin A. Retinal Icam1 and Cd40 mRNA levels were examined using real-time PCR. Protein nitration was assessed by immunohistochemistry. Histopathology was examined in the retinal vasculature. CD40 expression was assessed by flow cytometry and immunohistochemistry. Intercellular adhesion molecule 1 (ICAM-1) and nitric oxide synthase 2 (NOS2) were examined by immunoblot and/or flow cytometry. Nitric oxide production was examined by immunoblot and Griess reaction.

Results

In mouse models of diabetes, Cd40 −/− mice exhibited reduced retinal leucostasis and did not develop capillary degeneration in comparison with B6 mice. Diabetic Cd40 −/− mice had diminished ICAM-1 upregulation and decreased protein nitration. Cd40 mRNA levels were increased in the retinas of diabetic B6 mice compared with non-diabetic controls. CD40 expression increased in retinal Müller cells, endothelial cells and microglia of diabetic animals. CD40 stimulation upregulated ICAM-1 in retinal endothelial cells and Müller cells. CD40 ligation upregulated NOS2 and nitric oxide production by Müller cells.

Conclusions/interpretation

CD40-deficient mice were protected from the development of diabetic retinopathy. These mice exhibited diminished inflammatory responses linked to diabetic retinopathy. CD40 stimulation of retinal cells triggered these pro-inflammatory responses.
Literatur
1.
Zurück zum Zitat Mizutani M, Kern TS, Lorenzi M (1996) Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97:2883–2890PubMedCentralPubMedCrossRef Mizutani M, Kern TS, Lorenzi M (1996) Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97:2883–2890PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat McLeod DS, Lefer DJ, Merges C, Lutty GA (1995) Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147:642–653PubMedCentralPubMed McLeod DS, Lefer DJ, Merges C, Lutty GA (1995) Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147:642–653PubMedCentralPubMed
4.
Zurück zum Zitat Joussen AM, Poulaki V, Le ML et al (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18:1450–1452PubMed Joussen AM, Poulaki V, Le ML et al (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18:1450–1452PubMed
5.
Zurück zum Zitat Abu El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K (2001) Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 132:551–556PubMedCrossRef Abu El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K (2001) Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 132:551–556PubMedCrossRef
6.
Zurück zum Zitat Du Y, Smith MA, Miller CM, Kern TS (2002) Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80:771–779PubMedCrossRef Du Y, Smith MA, Miller CM, Kern TS (2002) Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80:771–779PubMedCrossRef
7.
Zurück zum Zitat Zheng L, Du Y, Miller C et al (2007) Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50:1987–1996PubMedCrossRef Zheng L, Du Y, Miller C et al (2007) Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50:1987–1996PubMedCrossRef
8.
Zurück zum Zitat Leal EC, Manivannan A, Hosoya K-I et al (2007) Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48:5257–5265PubMedCrossRef Leal EC, Manivannan A, Hosoya K-I et al (2007) Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48:5257–5265PubMedCrossRef
9.
Zurück zum Zitat van Kooten C, Banchereau J (2000) CD40-CD40 ligand. J Leuk Biol 67:2–17 van Kooten C, Banchereau J (2000) CD40-CD40 ligand. J Leuk Biol 67:2–17
11.
Zurück zum Zitat Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394:200–203PubMedCrossRef Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394:200–203PubMedCrossRef
12.
Zurück zum Zitat Lutgens E, Gorelik L, Daemen MJAP et al (1999) Requirement for CD154 in the progression of atherosclerosis. Nat Med 5:1313–1316PubMedCrossRef Lutgens E, Gorelik L, Daemen MJAP et al (1999) Requirement for CD154 in the progression of atherosclerosis. Nat Med 5:1313–1316PubMedCrossRef
13.
Zurück zum Zitat Portillo J-AC, Okenka G, Kern TS, Subauste CS (2009) Identification of primary retinal cells and ex vivo identification of pro-inflammatory molecules in retinal cells using flow cytometry. Mol Vis 15:1383–1389PubMedCentralPubMed Portillo J-AC, Okenka G, Kern TS, Subauste CS (2009) Identification of primary retinal cells and ex vivo identification of pro-inflammatory molecules in retinal cells using flow cytometry. Mol Vis 15:1383–1389PubMedCentralPubMed
14.
Zurück zum Zitat Yngen M, Ostenson C-G, Hu HM, Li N, Hjemdahl P, Wallen NH (2004) Enhanced P-selectin expression and increased soluble CD40 ligand in patients with type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia 47:537–540PubMedCrossRef Yngen M, Ostenson C-G, Hu HM, Li N, Hjemdahl P, Wallen NH (2004) Enhanced P-selectin expression and increased soluble CD40 ligand in patients with type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia 47:537–540PubMedCrossRef
15.
Zurück zum Zitat Portillo J-AC, van Grol J, Zheng L et al (2008) CD40 mediates retinal inflammation and neuro-vascular degeneration. J Immunol 181:8719–8726PubMedCrossRef Portillo J-AC, van Grol J, Zheng L et al (2008) CD40 mediates retinal inflammation and neuro-vascular degeneration. J Immunol 181:8719–8726PubMedCrossRef
16.
Zurück zum Zitat Schroder K, Vecchione C, Jung O et al (2006) Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. Free Radic Biol Med 41:1353–1360PubMedCrossRef Schroder K, Vecchione C, Jung O et al (2006) Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. Free Radic Biol Med 41:1353–1360PubMedCrossRef
17.
Zurück zum Zitat Zheng L, Szabo C, Kern TS (2004) Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor kappaB. Diabetes 53:2960–2967PubMedCrossRef Zheng L, Szabo C, Kern TS (2004) Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor kappaB. Diabetes 53:2960–2967PubMedCrossRef
18.
Zurück zum Zitat Capetandes A, Gerritsen ME (1990) Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes. Invest Ophthalmol Vis Sci 31:1738–1744PubMed Capetandes A, Gerritsen ME (1990) Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes. Invest Ophthalmol Vis Sci 31:1738–1744PubMed
19.
Zurück zum Zitat Puro DG (1994) Calcium channels of human retinal glial cells. In: Narahashi T (ed) Ion channels of excitable cells. Methods in neurosciences, vol. 19. Academic, Orlando, pp 68–81CrossRef Puro DG (1994) Calcium channels of human retinal glial cells. In: Narahashi T (ed) Ion channels of excitable cells. Methods in neurosciences, vol. 19. Academic, Orlando, pp 68–81CrossRef
20.
Zurück zum Zitat Bajorath J, Seyama K, Nonoyama S, Ochs HD, Aruffo A (1996) Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome. Protein Sci 5:531–534PubMedCentralPubMedCrossRef Bajorath J, Seyama K, Nonoyama S, Ochs HD, Aruffo A (1996) Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome. Protein Sci 5:531–534PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Scheef E, Wang S, Sorenson CM, Sheibani N (2005) Isolation and characterization of murine retinal astrocytes. Mol Vis 11:613–624PubMed Scheef E, Wang S, Sorenson CM, Sheibani N (2005) Isolation and characterization of murine retinal astrocytes. Mol Vis 11:613–624PubMed
22.
Zurück zum Zitat Gubitosi-Klug RA, Talahalli R, Du Y, Nadler JL, Kern TS (2008) 5-Lipoxygenase but not 12/15-lipoxygenase contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes 57:1387–1393PubMedCrossRef Gubitosi-Klug RA, Talahalli R, Du Y, Nadler JL, Kern TS (2008) 5-Lipoxygenase but not 12/15-lipoxygenase contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes 57:1387–1393PubMedCrossRef
23.
Zurück zum Zitat Ohh M, Smith CA, Carpenito C, Takei F (1994) Regulation of intracellular adhesion molecule-1 gene expression involves multiple mRNA stabilization mechanisms: effects of inteferon-γ and phorbol myristate acetate. Blood 84:2632–2639PubMed Ohh M, Smith CA, Carpenito C, Takei F (1994) Regulation of intracellular adhesion molecule-1 gene expression involves multiple mRNA stabilization mechanisms: effects of inteferon-γ and phorbol myristate acetate. Blood 84:2632–2639PubMed
24.
Zurück zum Zitat Nagai N, Izumi-Nagai K, Oike Y et al (2007) Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-κB pathway. Invest Ophthalmol Vis Sci 48:4342–4350PubMedCrossRef Nagai N, Izumi-Nagai K, Oike Y et al (2007) Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-κB pathway. Invest Ophthalmol Vis Sci 48:4342–4350PubMedCrossRef
25.
Zurück zum Zitat Bruemmer D, Riggers U, Holzmeister J et al (2001) Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions. Am J Cardiol 87:21–27PubMedCrossRef Bruemmer D, Riggers U, Holzmeister J et al (2001) Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions. Am J Cardiol 87:21–27PubMedCrossRef
26.
Zurück zum Zitat Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS (1995) CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A 92:4342–4346PubMedCentralPubMedCrossRef Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS (1995) CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A 92:4342–4346PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Subauste CS, Wessendarp M (2000) Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-γ. J Immunol 165:1498–1505PubMedCrossRef Subauste CS, Wessendarp M (2000) Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-γ. J Immunol 165:1498–1505PubMedCrossRef
28.
Zurück zum Zitat El-Remessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW, Caldwell RB (2003) Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 162:1995–2004PubMedCentralPubMedCrossRef El-Remessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW, Caldwell RB (2003) Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 162:1995–2004PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Kowluru RA, Kanwar M, Kennedy A (2007) Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res 2007:21976PubMedCentralPubMed Kowluru RA, Kanwar M, Kennedy A (2007) Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res 2007:21976PubMedCentralPubMed
30.
Zurück zum Zitat Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB (2008) Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 57:889–898PubMedCrossRef Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB (2008) Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 57:889–898PubMedCrossRef
31.
Zurück zum Zitat Kowluru RA (2003) Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52:818–823PubMedCrossRef Kowluru RA (2003) Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52:818–823PubMedCrossRef
32.
Zurück zum Zitat Kanwar M, Chan PS, Kern TS, Kowluru RA (2007) Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 48:3805–3811PubMedCrossRef Kanwar M, Chan PS, Kern TS, Kowluru RA (2007) Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 48:3805–3811PubMedCrossRef
33.
Zurück zum Zitat Jana M, Liu X, Koka S, Ghosh S, Petro TM, Pahan K (2001) Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J Biol Chem 276:44527–44533PubMedCentralPubMedCrossRef Jana M, Liu X, Koka S, Ghosh S, Petro TM, Pahan K (2001) Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J Biol Chem 276:44527–44533PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Urbich C, Dernbach E, Aicher A, Zeiher AM, Dimmeler S (2002) CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106:981–986PubMedCrossRef Urbich C, Dernbach E, Aicher A, Zeiher AM, Dimmeler S (2002) CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106:981–986PubMedCrossRef
35.
Zurück zum Zitat Lieth E, Barber AJ, Xu B et al (1998) Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 47:815–820PubMedCrossRef Lieth E, Barber AJ, Xu B et al (1998) Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 47:815–820PubMedCrossRef
36.
Zurück zum Zitat Gerbardinger C, Biarnes Costa M, Coulombe MC, Toth I, Hoehn T, Grosu P (2005) Expression of acute-phase response proteins in retinal Müller cells in diabetes. Invest Ophthalmol Vis Sci 46:349–357CrossRef Gerbardinger C, Biarnes Costa M, Coulombe MC, Toth I, Hoehn T, Grosu P (2005) Expression of acute-phase response proteins in retinal Müller cells in diabetes. Invest Ophthalmol Vis Sci 46:349–357CrossRef
37.
Zurück zum Zitat Meleth AD, Agron E, Cha C-C et al (2005) Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46:4295–4301PubMedCrossRef Meleth AD, Agron E, Cha C-C et al (2005) Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46:4295–4301PubMedCrossRef
38.
Zurück zum Zitat Rungger-Brandle E, Dosso AA, Leuenberger PM (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1971–1980PubMed Rungger-Brandle E, Dosso AA, Leuenberger PM (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1971–1980PubMed
39.
Zurück zum Zitat Henn V, Slupsky JR, Grafe M et al (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591–594PubMedCrossRef Henn V, Slupsky JR, Grafe M et al (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591–594PubMedCrossRef
40.
Zurück zum Zitat Boeri D, Maiello M, Lorenzi M (2001) Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 50:1432–1439PubMedCrossRef Boeri D, Maiello M, Lorenzi M (2001) Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 50:1432–1439PubMedCrossRef
41.
Zurück zum Zitat Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA (2001) The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98:1047–1053PubMedCrossRef Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA (2001) The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98:1047–1053PubMedCrossRef
42.
Zurück zum Zitat Varo N, Vincent D, Libby P et al (2003) Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients. A novel target of thiazolidinediones. Circulation 107:2644–2649CrossRef Varo N, Vincent D, Libby P et al (2003) Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients. A novel target of thiazolidinediones. Circulation 107:2644–2649CrossRef
43.
Zurück zum Zitat Cipollone F, Chiarelli F, Davi G et al (2005) Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia 48:1216–1224PubMedCrossRef Cipollone F, Chiarelli F, Davi G et al (2005) Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia 48:1216–1224PubMedCrossRef
44.
Zurück zum Zitat Portillo J-AC, Muniz-Feliciano L, Subauste MC, Heinzel FP, Subauste CS (2012) CD40 and TNF-α synergize to induce nitric oxide synthase in macrophages. Immunology 135:140–150PubMedCentralPubMedCrossRef Portillo J-AC, Muniz-Feliciano L, Subauste MC, Heinzel FP, Subauste CS (2012) CD40 and TNF-α synergize to induce nitric oxide synthase in macrophages. Immunology 135:140–150PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D (1995) Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155:4917–4925PubMed Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D (1995) Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155:4917–4925PubMed
Metadaten
Titel
CD40 promotes the development of early diabetic retinopathy in mice
verfasst von
Jose-Andres C. Portillo
Jennifer A. Greene
Genevieve Okenka
Yanling Miao
Nader Sheibani
Timothy S. Kern
Carlos S. Subauste
Publikationsdatum
01.10.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 10/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3321-x

Weitere Artikel der Ausgabe 10/2014

Diabetologia 10/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.